Cargando…
Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients
BACKGROUND: Lung infection by various organisms is a characteristic feature of cystic fibrosis (CF). CFTR genotype effects acquisition of Pseudomonas aeruginosa (Pa), however the effect on acquisition of other infectious organisms that frequently precede Pa is relatively unknown. Understanding the r...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964615/ https://www.ncbi.nlm.nih.gov/pubmed/20932301 http://dx.doi.org/10.1186/1465-9921-11-140 |
_version_ | 1782189397934866432 |
---|---|
author | Green, Deanna M McDougal, Kathryn E Blackman, Scott M Sosnay, Patrick R Henderson, Lindsay B Naughton, Kathleen M Collaco, J Michael Cutting, Garry R |
author_facet | Green, Deanna M McDougal, Kathryn E Blackman, Scott M Sosnay, Patrick R Henderson, Lindsay B Naughton, Kathleen M Collaco, J Michael Cutting, Garry R |
author_sort | Green, Deanna M |
collection | PubMed |
description | BACKGROUND: Lung infection by various organisms is a characteristic feature of cystic fibrosis (CF). CFTR genotype effects acquisition of Pseudomonas aeruginosa (Pa), however the effect on acquisition of other infectious organisms that frequently precede Pa is relatively unknown. Understanding the role of CFTR in the acquisition of organisms first detected in patients may help guide symptomatic and molecular-based treatment for CF. METHODS: Lung infection, defined as a single positive respiratory tract culture, was assessed for 13 organisms in 1,381 individuals with CF. Subjects were divided by predicted CFTR function: 'Residual': carrying at least one partial function CFTR mutation (class IV or V) and 'Minimal' those who do not carry a partial function mutation. Kaplan-Meier estimates were created to assess CFTR effect on age of acquisition for each organism. Cox proportional hazard models were performed to control for possible cofactors. A separate Cox regression was used to determine whether defining infection with Pa, mucoid Pa or Aspergillus (Asp) using alternative criteria affected the results. The influence of severity of lung disease at the time of acquisition was evaluated using stratified Cox regression methods by lung disease categories. RESULTS: Subjects with 'Minimal' CFTR function had a higher hazard than patients with 'Residual' function for acquisition of 9 of 13 organisms studied (HR ranging from 1.7 to 3.78 based on the organism studied). Subjects with minimal CFTR function acquired infection at a younger age than those with residual function for 12 of 13 organisms (p-values ranging: < 0.001 to 0.017). Minimal CFTR function also associated with younger age of infection when 3 alternative definitions of infection with Pa, mucoid Pa or Asp were employed. Risk of infection is correlated with CFTR function for 8 of 9 organisms in patients with good lung function (>90%ile) but only 1 of 9 organisms in those with poorer lung function (<50%ile). CONCLUSIONS: Residual CFTR function correlates with later onset of respiratory tract infection by a wide spectrum of organisms frequently cultured from CF patients. The protective effect conferred by residual CFTR function is diminished in CF patients with more advanced lung disease. |
format | Text |
id | pubmed-2964615 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29646152010-10-28 Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients Green, Deanna M McDougal, Kathryn E Blackman, Scott M Sosnay, Patrick R Henderson, Lindsay B Naughton, Kathleen M Collaco, J Michael Cutting, Garry R Respir Res Research BACKGROUND: Lung infection by various organisms is a characteristic feature of cystic fibrosis (CF). CFTR genotype effects acquisition of Pseudomonas aeruginosa (Pa), however the effect on acquisition of other infectious organisms that frequently precede Pa is relatively unknown. Understanding the role of CFTR in the acquisition of organisms first detected in patients may help guide symptomatic and molecular-based treatment for CF. METHODS: Lung infection, defined as a single positive respiratory tract culture, was assessed for 13 organisms in 1,381 individuals with CF. Subjects were divided by predicted CFTR function: 'Residual': carrying at least one partial function CFTR mutation (class IV or V) and 'Minimal' those who do not carry a partial function mutation. Kaplan-Meier estimates were created to assess CFTR effect on age of acquisition for each organism. Cox proportional hazard models were performed to control for possible cofactors. A separate Cox regression was used to determine whether defining infection with Pa, mucoid Pa or Aspergillus (Asp) using alternative criteria affected the results. The influence of severity of lung disease at the time of acquisition was evaluated using stratified Cox regression methods by lung disease categories. RESULTS: Subjects with 'Minimal' CFTR function had a higher hazard than patients with 'Residual' function for acquisition of 9 of 13 organisms studied (HR ranging from 1.7 to 3.78 based on the organism studied). Subjects with minimal CFTR function acquired infection at a younger age than those with residual function for 12 of 13 organisms (p-values ranging: < 0.001 to 0.017). Minimal CFTR function also associated with younger age of infection when 3 alternative definitions of infection with Pa, mucoid Pa or Asp were employed. Risk of infection is correlated with CFTR function for 8 of 9 organisms in patients with good lung function (>90%ile) but only 1 of 9 organisms in those with poorer lung function (<50%ile). CONCLUSIONS: Residual CFTR function correlates with later onset of respiratory tract infection by a wide spectrum of organisms frequently cultured from CF patients. The protective effect conferred by residual CFTR function is diminished in CF patients with more advanced lung disease. BioMed Central 2010 2010-10-08 /pmc/articles/PMC2964615/ /pubmed/20932301 http://dx.doi.org/10.1186/1465-9921-11-140 Text en Copyright ©2010 Green et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Green, Deanna M McDougal, Kathryn E Blackman, Scott M Sosnay, Patrick R Henderson, Lindsay B Naughton, Kathleen M Collaco, J Michael Cutting, Garry R Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients |
title | Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients |
title_full | Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients |
title_fullStr | Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients |
title_full_unstemmed | Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients |
title_short | Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients |
title_sort | mutations that permit residual cftr function delay acquisition of multiple respiratory pathogens in cf patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964615/ https://www.ncbi.nlm.nih.gov/pubmed/20932301 http://dx.doi.org/10.1186/1465-9921-11-140 |
work_keys_str_mv | AT greendeannam mutationsthatpermitresidualcftrfunctiondelayacquisitionofmultiplerespiratorypathogensincfpatients AT mcdougalkathryne mutationsthatpermitresidualcftrfunctiondelayacquisitionofmultiplerespiratorypathogensincfpatients AT blackmanscottm mutationsthatpermitresidualcftrfunctiondelayacquisitionofmultiplerespiratorypathogensincfpatients AT sosnaypatrickr mutationsthatpermitresidualcftrfunctiondelayacquisitionofmultiplerespiratorypathogensincfpatients AT hendersonlindsayb mutationsthatpermitresidualcftrfunctiondelayacquisitionofmultiplerespiratorypathogensincfpatients AT naughtonkathleenm mutationsthatpermitresidualcftrfunctiondelayacquisitionofmultiplerespiratorypathogensincfpatients AT collacojmichael mutationsthatpermitresidualcftrfunctiondelayacquisitionofmultiplerespiratorypathogensincfpatients AT cuttinggarryr mutationsthatpermitresidualcftrfunctiondelayacquisitionofmultiplerespiratorypathogensincfpatients |